Preferential induction of transforming growth factor-β production in gastric epithelial cells and monocytes by Helicobacter pylori soluble proteins

Journal of Infectious Diseases

Volumn 196, Issue 9, 2007, Pages 1386-1393

  Wu, Ming Shiang ^a   Lin, Jaw Town ^a   Hsu, Ping Ning ^a   Lin, Ching Yi ^b   Hsieh, Yuan Ting ^b   Chiu, Yi Han ^b   Hsueh, Po Ren ^a   Liao, Kuang Wen ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; BACTERIAL ANTIGEN; CAGA PROTEIN, HELICOBACTER PYLORI; UNCLASSIFIED DRUG; VACA PROTEIN, HELICOBACTER PYLORI;

ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUODENUM ULCER; ENTEROBACTERIACEAE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCYTE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH ULCER; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; GENETICS; METABOLISM; STOMACH; TUMOR CELL LINE;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE, TUMOR; EPITHELIAL CELLS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-10; MONOCYTES; STOMACH; TRANSFORMING GROWTH FACTOR BETA;

EID: 38449099432     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522520     Document Type: Article

References (41)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347:1175-86.
2. Blaser MJ. Polymorphic bacteria persisting in polymorphic hosts. J Natl Cancer Inst 2002; 94:1662-3.
3. Ibraghimov A, Pappo J. The immune response against Helicobacter pylori - a direct linkage to the development of gastroduodenal disease. Microbes Infect 2000; 2:1073-7.
4. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998; 54:139-50.
5. Ismail HF, Fick P, Zhang J, Lynch RG, Berg, DJ. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003; 170:3782-9.
6. Hamilton-Easton A, Eichelberger M. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J Virol 1995; 69:6359-66.
7. Veenendaal RA, Gotz JM, Schroijen V, et al. Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies. J Clin Pathol 1995; 48:990-3.
8. Roth KA, Kapadia SB, Martin SM, Lorenz RG. Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J Immunol 1999; 163:1490-7.
9. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 2001; 166:7456-61.
10. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56:3238-43.
11. Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immunol 2001; 167:926-34.
12. Gobert AP, Cheng Y, Wang JY, et al. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol 2002; 168:4692-700.
13. D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997; 158:962-7.
14. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith, PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000; 165:1022-9.
15. Meyer F, Ramanujam KS, Gobert AP, James SP, Wilson KT. Cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori. J Immunol 2003; 171:3913-7.
16. Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 2001; 15:1271-90.
17. Fan XJ, Chua A, Shahi CN, McDevitt J, Keeling PWN, Kelleher D. Gastric T lymphocyte responses to Helicobacter pylori colonization. Gut 1994; 35:1379-84.
18. Karttunen RA, Karttunen T, Ekre HP, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995; 36:341-5.
19. D'Elios MM, Manghetti M, Almerigogna F, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997; 27:1751-5.
20. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002; 23:450-5.
21. Luethviksson BR, Gunnlaugdottir B. Transforming growth factor-β as a regulator of site-specific T-cell inflammatory response. Scand J Immunol 2003; 58:129-38.
22. Streilein JW, Masli S, Takeuchi M, Kezuka T. The eye's view of antigen presentation. Hum Immunol 2002; 63:435-43.
23. Haeberle HA, Kubin M, Banford KB, et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and associations of IL-12 production with gamma-interferon producing T cells in the human gastric mucosa. Infect Immun 1997; 65:4229-35.
24. Alkout AM, Blackwell CC,Weir DM. Increased inflammatory responses of persons of blood group O to Helicobacter pylori. J Infect Dis 2000; 181:1364-9.
25. Meyer F,Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 2000; 68:6265-72.
26. Lindholm C, Quiding-Jarbrink M, Lonroth H, Svennerholm AM. Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants. Scand J Gastroenterol 2001; 36:1022-9.
27. Guiney DG, Hasegawa P, Cole SP. Helicobacter pyolori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 2003; 71:4163-6.
28. Takagi A, Kamiya S, Koga Y, et al. Analysis of interleukin-8 secretion induced by Helicobacter pylori from the gastric epithelial cell line MKN45: a mechanism independent of the intensity of cytotoxicity. J Gastroenterol Hepatol 1997; 12:368-72.
29. Messa C, DiLeo A, Greco B, et al. Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. Immunopharmacol Immunotoxicol 1996; 18:1-13.
30. Nakachi N, Klein TK, Friedman H, Yamamoto Y. Helicobacter pylori infection of human gastric epithelial cells induces IL-8 and TNF-α but not TGF-β 1 mRNA. FEMS Immunol Med Microbiol 2000; 29:23-6.
31. Stromberg E, Edebo A, Svennerholm AM, Lindholm C. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin Diagn Lab Immunol 2003; 10:116-24.
32. Lai Y-P, Yang J-C, Lin T-Z, Wang J-T, Lin J-T. cagA Tyroine phosphorylation in gastric epithelial cells caused by Helicobacter pylori in patients with gastric adenocarcinoma. Helicobacter 2003; 8:235-43.
33. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001; 19:523-63.
34. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66:5964-71.
35. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996; 110:1744-52.
36. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett 2002; 82:85-91.
37. Buzoni-Gatel D, Debbabi H, Mennechet FJ, et al. Murine ileitis after intracellular parasite infection is controlled by TGF-β-producing intraepithelial lymphocytes. Gastroenterology 2001; 120:914-24.
38. Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 2002; 168:900-8.
39. Hahm KB, Lee KM, Kim YB, et al. Conditional loss of TGF-β signaling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2002; 16(Suppl 2):115-27.
40. Engle SJ, Ormshy I, Pawlowski S, et al. Elimination of colon cancer in germ-free transforming growth factor β 1-deficient mice. Cancer Res 2002; 62:6362-6.
41. Chang J, Park K, Bang YJ, Kim WS, Kim D, Kim SJ. Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 1997; 57:2856-9.